Posts

Posted on

An evil race that hopes to rule the universe seeks the White Queen’s power and she intends to stop them at any cost

J.M. Mills announces the release of ‘The Gathering: The White Queen’

PERTH, Australia, Nov. 28, 2020 (GLOBE NEWSWIRE) — “I love fantasy and sci-fi. A dream that kept repeating over and over for the last 20 years was always something I wanted to write about. I had never written before, or had the urge to, but I had enough passion to give it a go,” J.M. Mills states. Now, she finally releases her first fantasy/sci-fi novel, “The Gathering: The White Queen” (published by Balboa Press AU).

 

Thrown into inter-dimensional space and time, onto a foreign planet, by the creators of the universe. Koby must gather an elite group of kindred, to learn their skills, and save them from an off-world threat. Foretold in a prophecy, Koby must make her peace with the creators in time to overthrow a race of superior beings. The Territes are trying to locate several artifacts to help them rule the universe, and the White Queen is the keeper of one very powerful artifact — herself, and the five keys of creation.

 

Can Koby come to grips with her change in life, becoming a Queen, and gather enough power to overthrow the most ruthless race the galaxy has ever known? Will her White Order army of Vampires, Mage, Faerie, Vanishers and a Knight, be enough to stop total domination?

 

“There are multiple plots, endless struggles and continual surprises with a plot twist no one will see coming. There are many answers to questions that need to be discovered, therefore, the reader needs to pay attention to the story, and how it’s being told,” Mills says. When asked what she wants readers to take away from his writing of this book, she replies, “Enjoyment from sitting down and reading an intriguing story that makes them cheer for the characters. Anyone can do anything if they set their mind to it.” For more details about this book, please visit https://www.balboapress.com/en-au/bookstore/bookdetails/814631-the-gathering

 

“The Gathering: The White Queen”

By J. M. Mills

Softcover | 6 x 9in | 396 pages | ISBN 9781504322263

E-Book | 396 pages | ISBN 9781504322270

Available at Amazon and Barnes & Noble

 

About the Author

J. M. Mills was born in Western Australia and raised in the small coal-mining town of Collie. She has managed to attain three degrees, a dog and a house. Writing her second novel, undertaking her first screenplay and loving life by writing her poetry, she considers herself in a happy place.

 

Balboa Press Australia is a division of Hay House, Inc., a leading provider in publishing products that specialise in self-help and the mind, body and spirit genre. Through an alliance with the worldwide self-publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the Author Solutions self-publishing model. For more information or to start publishing today, visit balboapress.com.au/ or call 1-800-844-925.

Attachment 



Marketing Services
Balboa Press AU
1-800-844-925
[email protected]

Posted on

PGEN 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Precigen, Inc. (PGEN) Investors with Losses to Contact Its Attorneys, Securities Fraud Deadline Approaching

SAN FRANCISCO, Nov. 28, 2020 (GLOBE NEWSWIRE) — Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securities fraud class action has been filed and certain investors may have sufficient losses to move for lead plaintiff.

Class
Period: May 10, 2017 – Sept. 25, 2020
Lead Plaintiff Deadline: Dec. 4, 2020
Visit:www.hbsslaw.com/investor-fraud/PGEN
Contact An Attorney Now:[email protected] | 844-916–0895

Precigen
, Inc.
(
PGEN
)
Securities Fraud Class Action
:

The complaint alleges that Defendants misrepresented and concealed that: (1) the Company was using pure methane as feedstock for its announced yields for its methanotroph bioconversion (“MCB”) platform instead of natural gas; (2) yields from natural gas as a feedstock were substantially lower than the announced pure methane yields; (3) due to the substantial price difference between pure methane and natural gas, pure methane was not a commercially viable feedstock; (4) the Company’s 1Q 2018 financial statements were false; (5) the Company had material weaknesses in its internal controls over financial reporting; and (6) the Company was under investigation by the SEC since October 2018.

Investors allegedly began to learn the truth through a series of disclosures beginning on Aug. 9, 2018, when the company announced that its 1Q 2018 financial results could no longer be relied on. In its restated 1Q 2018 results, the company made significant changes to deferred revenue, collaboration and licensing revenues and accumulated deficit, as well as admitted to material weaknesses in its internal controls over financial reporting.

Then, on Mar. 2, 2020, the company disclosed it received a subpoena in Oct. 2018 from the SEC concerning Precigen’s MCB-related disclosures.

Finally, on Sept. 25, 2020, the SEC issued a cease and desist order involving “inaccurate reports concerning the company’s purported success converting relatively inexpensive natural gas into more expensive industrial chemicals using a proprietary [MCB] program.”

“We’re focused on investors’ losses and proving that Precigen cooked its books and promoted fake technology,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you are a Precigen investor and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Precigen should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844–916–0895 or email [email protected].


About Hagens Berman


Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact
:

Reed Kathrein, 844-916-0895



Posted on

New book narrates the touching story of a woman’s journey from grief to healing through an odyssey around the world

Hélène Jermolajew announces the release of “Journeys With My Mother’s Ashes: Healing Grief Through Travel”

CANBERRA, Australia, Nov. 28, 2020 (GLOBE NEWSWIRE) — After the death of her mother and 12 months of travel, Hélène Jermolajew felt a strong pull to share her experience of grief and healing. “Journeys With My Mother’s Ashes: Healing Grief Through Travel” (published by Balboa Press AU) shares a story that documents her journey.

 

This book describes the trauma faced by a daughter who has to maneuver the pitfalls and traps after the death of her mother. She realizes that the only way toward her healing is to leave the country of her birth and travel the world taking her mother’s ashes with her. Here, she invites readers to join her on a grand tour through life, death, drama, family, healing and lots of travel.

 

There are many moments of both darkness and light, fun and reflection, exploration and realizations and most of all, a sense of direction to a brighter future through trusting her intuition. The journey has very few plans yet provides exactly what Jermolajew needs through trusting both a loving universe and herself.

 

“Those who have lost loved ones to death know how hard it is to work their way through the grieving process and many search for books written by those who have found a way through their grief,” Jermolajew says. “This is a book where they will see that not only is it possible but they are not alone because many of us have been there.”

 

The publication of “Journeys With My Mother’s Ashes: Healing Grief Through Travel” aims for those who lost their loved ones to know that they are not alone and that there is at least one person in this world who understands them, to take away some positive thoughts about their own grief journey and that it is possible to find a way to heal and not to be stuck with the demons of grief as well as to put aside their sad thoughts and enjoy a little bit of travel through Jermolajew’s eyes. For more details about the book, please visit https://www.balboapress.com/en-au/bookstore/bookdetails/799100-journeys-with-my-mothers-ashes

 

“Journeys With My Mother’s Ashes: Healing Grief Through Travel”

By Hélène Jermolajew

Softcover | 6 x 9in | 264 pages | ISBN 9781504322843

E-Book | 264 pages | ISBN 9781504322881

Available at Amazon and Barnes & Noble

About the Author

Hélène Jermolajew is a published poet. Some of the poems in her collection titled “Laughter, Tears and Coffee” appear in this memoir. Her favorite reading material are real stories, memoirs, biographies and self-help books amongst many others although an odd novel does find its way into her hands. She loves languages and reads for both the information in a book and the way language is used to tell a story. Her own style is conversational, she prefers to tell a casual story over a cup of coffee or a glass of wine. She is the mother of two wonderful sons, grandmother to three beautiful grandchildren and has the two most incredible daughters-in-law anyone could ask for.

Balboa Press Australia is a division of Hay House, Inc., a leading provider in publishing products that specialise in self-help and the mind, body and spirit genre. Through an alliance with the worldwide self-publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the Author Solutions self-publishing model. For more information or to start publishing today, visit balboapress.com.au/ or call 1-800-844-925.

Attachment 



Marketing Services
Balboa Press AU
1-800-844-925
[email protected]

Posted on

ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Interface, Inc. Investors of Important January 11 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – TILE

PR Newswire

NEW YORK, Nov. 28, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Interface, Inc. (NASDAQ: TILE) between March 2, 2018 and September 28, 2020, inclusive (the “Class Period”) of the important January 11, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Interface investors under the federal securities laws.

To join the Interface class action, go to http://www.rosenlegal.com/cases-register-1788.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (2) consequently, Interface, among other things, reported artificially inflated income and earnings per share (EPS) in 2015 and 2016; (3) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing since at least November 2017, had impeded the SEC’s investigation, and downplayed the true scope of Interface’s wrongdoing and liability with respect to the SEC investigation; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 11, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1788.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-trusted-investor-counsel-reminds-interface-inc-investors-of-important-january-11-deadline-in-securities-class-action-encourages-investors-with-losses-in-excess-of-100k-to-contact-firm–tile-301180894.html

SOURCE Rosen Law Firm, P.A.

Posted on

Dr. Reddy’s to Acquire Select Anti-Allergy Brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan

Dr. Reddy’s to Acquire Select Anti-Allergy Brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan

 

HYDERABAD, India–(BUSINESS WIRE)–
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a definitive agreement with Glenmark Pharmaceuticals Ltd. to acquire, subject to completion of certain precedent actions and closing activities, brands Momat Rino (for Russia, Kazakhstan and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan and Uzbekistan), Glenspray and Glenspray Active (for Ukraine), along-with rights to the trademarks, dossiers and patents for the territories mentioned.

The acquired brands represent two types of products, (a) mometasone mono product and (b) combination of mometasone with azelastine, and are indicated for the treatment of Seasonal and Perennial Allergic Rhinitis.

M V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets) of Dr. Reddy’s said, “The new brands are a great addition to our product portfolio in Russia, Ukraine, Kazakhstan and Uzbekistan which are important core markets for us. Momat Rino, the largest brand acquired, has recently received OTC registration in Russia and this will enable accelerated access of this product to patients.

The acquired products will further add to Dr. Reddy’s strong presence in the anti-allergy segment in these countries, and will also enable us to offer a more comprehensive solution to patients in this area.”

……………………………………………………………………………………..……………………………………………………………………………………………………………………..……………….

About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to:www.drreddys.com

……………………………………………………………………………………………………………………………………………………………………..

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management’s current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words “may”, “will”, “should”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue” and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates, interest rates, persistency levels and frequency / severity of insured loss events, (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization, including related integration issues, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers’, products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or COVID-19), and (vii) other risks and uncertainties identified in our public filings with the Securities and Exchange Commission, including those listed under the “Risk Factors” and “Forward-Looking Statements” sections of our Annual Report on Form 20-F for the year ended March 31, 2020. The company assumes no obligation to update any information contained herein.”

INVESTOR RELATIONS

AMIT AGARWAL

[email protected]

(PH: +91-40-49002135)

MEDIA RELATIONS

APARNA TEKURI

[email protected]

(PH: +91-40- 49002446)

KEYWORDS: New York United States India North America Asia Pacific

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health

MEDIA:

Logo
Logo
Posted on

FINAL DEADLINE ALERT: Rosen, Respected Investor Counsel, Reminds Pintec Technology Holdings Limited Investors of Important November 30 Deadline in Securities Class Action – PT

PR Newswire

NEW YORK, Nov. 28, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pintec Technology Holdings Limited (NASDAQ: PT) pursuant and/or traceable to the registration statement issued in connection with Pintec’s October 2018 initial public offering (the “IPO”), of the important November 30, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Pintec investors under the federal securities laws.

To join the Pintec class action, go to http://www.rosenlegal.com/cases-register-1608.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, the registration statement was false and misleading and omitted to state material facts. Specifically, defendants failed to disclose to investors that: (1) Pintec erroneously recorded revenue earned from certain technical service fees on a net basis, rather than a gross basis; (2) there were material weaknesses in Pintec’s internal control over financial reporting related to cash advances outside the normal course of business to Jimu Group, a related party, and to a non-routine loan financing transaction with a third-party entity, Plutux Labs; (3) as a result of the foregoing, Pintec’s financial results for fiscal 2017 and 2018 had been misstated; and (4) as a result of the foregoing, defendants’ positive statements about Pintec’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 30, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1608.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/final-deadline-alert-rosen-respected-investor-counsel-reminds-pintec-technology-holdings-limited-investors-of-important-november-30-deadline-in-securities-class-action–pt-301180892.html

SOURCE Rosen Law Firm, P.A.

Posted on

ROSEN, A LEADING LAW FIRM, Reminds Turquoise Hill Resources Ltd. Investors of Important December 14 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – TRQ

PR Newswire

NEW YORK, Nov. 28, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Turquoise Hill Resources Ltd. (NYSE: TRQ) between July 17, 2018 and July 31, 2019, inclusive (the “Class Period”), of the important December 14, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Turquoise Hill investors under the federal securities laws.

To join the Turquoise Hill class action, go to http://www.rosenlegal.com/cases-register-1971.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, throughout the Class Period and regarding the development of the Oyu Tolgoi copper-gold mine in Mongolia, defendants made false and/or misleading statements and/or failed to disclose that: (1) the stability issues were much more severe than represented and called into question the design of the mine, the projected cost and timing of production; (2) the publicly disclosed estimates of the cost, date of completion and dates for production from the underground mine were not achievable; (3) the “challenging ground conditions” were much more severe than defendants represented, and in fact made it impossible for Turquoise Hill and Rio Tinto to achieve those estimates; (4) the development capital required for the underground development of Oyu Tolgoi would cost substantially more than a billion dollars over what Turquoise Hill and Rio Tinto had represented; (5) Turquoise Hill would require additional financing and/or equity to complete the project; (6) the progress of underground development and of Oyu Tolgoi was not proceeding as planned; and (7) the “key risks” had not been “well understood and managed” but had placed the project schedule and cost into severe jeopardy. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 14, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1971.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq. 
      Phillip Kim, Esq. 
      The Rosen Law Firm, P.A. 
      275 Madison Avenue, 40th Floor 
      New York, NY 10016 
      Tel: (212) 686-1060 
      Toll Free: (866) 767-3653 
      Fax: (212) 202-3827 
      [email protected] 
      [email protected] 
      [email protected] 
      www.rosenlegal.com 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-a-leading-law-firm-reminds-turquoise-hill-resources-ltd-investors-of-important-december-14-deadline-in-securities-class-action-encourages-investors-with-losses-in-excess-of-100k-to-contact-the-firm–trq-301180796.html

SOURCE Rosen Law Firm, P.A.

Posted on

ROSEN, TOP RANKED INVESTOR COUNSEL, Reminds Zosano Pharma Corporation Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ZSAN

PR Newswire

NEW YORK, Nov. 28, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13, 2017 and September 30, 2020, inclusive (the “Class Period”), of the important December 28, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Zosano investors under the federal securities laws.

To join the Zosano class action, go to http://www.rosenlegal.com/cases-register-1963.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the Company’s clinical results reflected differences in zolmitriptan exposures observed between subjects receiving different lots; (2) pharmocokinetic studies submitted in connection with the Company’s New Drug Application (“NDA”) included patients exhibiting unexpected high plasma concentrations of zolmitriptan; (3) as a result of the foregoing differences among patient results, the U.S. Food and Drug Administration (“FDA”) was reasonably likely to require further studies to support regulatory approval of Qtrypta; (4) as a result, regulatory approval of Qtrypta was reasonably likely to be delayed; and (5) as a result of the foregoing, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 28, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1963.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-top-ranked-investor-counsel-reminds-zosano-pharma-corporation-investors-of-important-deadline-in-securities-class-action-encourages-investors-with-losses-in-excess-of-100k-to-contact-firm—zsan-301180795.html

SOURCE Rosen Law Firm, P.A.

Posted on

Shopify Announces Record Global Black Friday Sales of $2.4 Billion

Shopify Announces Record Global Black Friday Sales of $2.4 Billion

OTTAWA, Ontario–(BUSINESS WIRE)–
Today, Shopify Inc. (NYSE:SHOP)(TSX:SHOP), a leading global commerce company, announced record-setting Black Friday sales of $2.4 billion* from the independent and direct-to-consumer brands on the platform worldwide. On November 27, from the start of Black Friday in New Zealand through the end of Black Friday in California, Shopify-powered businesses saw a 75% increase in sales from Black Friday in 2019. In fact, by 8:00am EST, merchants on Shopify collectively had crossed $1 billion in sales.

“We’re thrilled with the Black Friday sales generated by the businesses on Shopify. In just a single day, merchants around the world produced more than 80% of the sales of the entire holiday shopping weekend last year,” said Harley Finkelstein, President of Shopify. “With more consumers than ever shopping online this year, we anticipate this weekend being one of the biggest ecommerce events in history, as consumers vote with their wallets and support the independent and direct-to-consumer businesses they love.”

2020 Black Friday Global Highlights**

  • $2.4 billion in Black Friday sales globally, a 75% growth in sales from last year
  • New York, London, and Los Angeles were the top-selling cities worldwide on Black Friday, with top-selling countries including US, UK,and Canada
  • Mobile sales on Black Friday were 67% compared to 33% of sales made on desktop. In 2019, 69% of Black Friday sales were made on mobile and 31% on desktop
  • Top product categories globally during Black Friday were apparel and accessories with health and beauty and home and garden following
  • Average Black Friday cart price globally was $90.70, an increase of 11% from last year
  • 14% of cross-border orders placed on the platform on Black Friday
  • 20,000+ tonnes of carbon emissions offset from the delivery of every order placed on Shopify’s platform on Black Friday

For a dynamic, real-time view of Black Friday/Cyber Monday commerce from Shopify’s more than one million independent businesses worldwide, visit datastories.shopify.com.

About Shopify

Shopify is a leading global commerce company, providing trusted tools to start, grow, market, and manage a retail business of any size. Shopify makes commerce better for everyone with a platform and services that are engineered for reliability, while delivering a better shopping experience for consumers everywhere. Headquartered in Ottawa, Canada, Shopify powers over one million businesses in more than 175 countries and is trusted by brands such as Allbirds, Gymshark, Heinz, Staples and many more.

Forward-looking Statements

This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws (“forward-looking statements“), including statements with regard to commerce trends. Words such as “expects”, “anticipates” and “intends” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions and no assurance can be given that these trends will continue. Shopify undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

+++

*Shopify’s 2020 Black Friday data is based on sales by its more than one million businesses in approximately 175 countries around the world from November 26th 11:00:00 UTC to November 28th 8:00:00 UTC.

**Shopify’s 2020 Black Friday data is based on sales by its more than one million businesses in approximately 175 countries around the world from November 27th 00:00 UTC to November 27th 24:00.

All data presented here (including worldwide sales) is approximate and is based on various assumptions. All data is unaudited and is subject to adjustment. All financial figures are in USD.

INVESTORS:

Katie Keita

Senior Director, Investor Relations

613-241-2828 x 1024

[email protected]

MEDIA:

Rebecca Feigelsohn

Communications Lead

416-238-6705 x 302

[email protected]

KEYWORDS: United States North America Canada

INDUSTRY KEYWORDS: Home Goods Internet Technology Online Retail Fashion Cosmetics Mobile/Wireless Retail

MEDIA:

Logo
Logo
Posted on

Horizons ETF Corp. Announces No Expected 2020 Dividends

Canada NewsWire

TORONTO, Nov. 27, 2020 /CNW/ – Horizons ETFs Management (Canada) Inc. (“Horizons ETFs“), the manager of the Horizons ETF Corp. (the “Company“), announced today that it does not expect that the Company will declare any dividends for the 2020 tax year.

The Corporation is currently comprised of 52 non-cumulative, redeemable, non-voting classes of shares (each, a “Corporate Class“) and one class of voting shares, and qualifies as a mutual fund corporation under the Income Tax Act (Canada) (the “Tax Act“). Each Corporate Class is a separate exchange traded fund (“ETF“) having specific investment objectives and is specifically referable to a separate portfolio of investments. Each ETF currently consists of a single series of exchange traded fund shares (“ETF Shares“) of the applicable Corporate Class.

Although the Company may issue shares in an unlimited number of classes, each issuable in an unlimited number of series, it will be required (like any other mutual fund corporation with a multi-class structure) to compute its income and net capital gains for tax purposes as a single entity. All of the Company’s revenues, deductible expenses, non-capital losses, capital gains and capital losses in connection with all of its investment portfolios, and other items relevant to its tax position (including the tax attributes of all of its assets), will be taken into account in determining the income (and taxable income) or loss of the Company and applicable taxes payable by the Company as a whole. For the 2020 tax year, the company does not expect to incur a tax liability for any taxable income.

As a mutual fund corporation, the Company will be entitled to maintain a capital gains dividend account in respect of its net realized capital gains and from which it may elect to pay dividends (“Capital Gains Dividends“) which are treated as capital gains in the hands of holders of ETF Shares (each, a “Holder“). For the 2020 tax year, the Company does expect to pay any Capital Gains Dividends.

A Holder will be required to include in income the amount of any dividends other than Capital Gains Dividends (“Ordinary Dividends“) paid on ETF Shares of an ETF, whether received in cash, in the form of ETF Shares or as cash which is reinvested in additional ETF Shares. The dividend gross-up and tax credit treatment normally applicable to taxable dividends (including eligible dividends) paid by a taxable Canadian corporation will generally apply to such dividends. For the 2020 tax year, the Company does expect to pay any Ordinary Dividends.

Please note that these are the expectations of Horizons ETFs at the time of this press release. Circumstances may arise which could cause these expectations to change before the Company’s tax year-end on December 31, 2020.

Horizons ETFs expects to announce its estimates for the 2020 year-end non-cash reinvested distributions for its actively managed and index replication ETFs in a separate press release, on or about December 4, 2020.

About Horizons ETFs Management (Canada) Inc. (www.HorizonsETFs.com)

Horizons ETFs Management (Canada) Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has more than $15.8 billion of assets under management and 93 ETFs listed on major Canadian stock exchanges.

Certain statements may constitute a forward-looking statement, including those identified by the expression “expect” and similar expressions (including grammatical variations thereof). The forward-looking statements are not historical facts but reflect the author’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. These and other factors should be considered carefully and readers should not place undue reliance on such forward looking statements. These forward-looking statements are made as of the date hereof and the authors do not undertake to update any forward-looking statement that is contained herein, whether as a result of new information, future events or otherwise, unless required by applicable law.

Commissions, management fees and expenses all may be associated with an investment in exchange traded products (the “Horizons Exchange Traded Products”) managed by Horizons ETFs Management (Canada) Inc. The Horizons Exchange Traded Products are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Horizons Exchange Traded Products. Please read the relevant prospectus before investing.
 

SOURCE Horizons ETFs Management (Canada) Inc.